Singapore - Agilent Technologies Inc. announced that it will increase its advanced manufacturing and applied research and development capabilities in Singapore with investments and business expenditures of $85 million SGD over the next five years.
These investments and expenditures will enable the Singapore facility to offer complete end-to-end manufacturing, test, and supply chain management, equipped with state-of-the-art automated systems.
Agilent will add 30,000 square feet within its existing facility and create approximately 100 new jobs in R&D, advanced manufacturing, service and sales over the next five years.
“Singapore is a strategic location for Agilent,” said Mike McMullen, Agilent president and CEO. “We appreciate the environment of innovation Singapore has created, as well as the important investments it is making in growing areas such as medical technology and biopharma.”
Agilent’s scientific instruments are used in markets such as environmental, chemical and energy; pharmaceutical, food testing and clinical laboratories around the world. Ultivo is the latest in Agilent’s portfolio of liquid-chromatography/mass-spectrometry instruments, and can be used to address food and environmental testing needs. Launched in June, it is 70 percent smaller than its predecessor but it delivers equal or better performance to much larger instruments, allowing customers to increase their analytical throughput without having to increase the size of their laboratories.
